Keio University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Keio University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014095
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Keio University (Keio) is an educational institution that offers academic and research in various fields. The university provides primary and secondary education, graduate and undergraduate courses, and information technology courses. It offers academic courses in the field of economics, law, humanities and social science, political science, and others. Keio also offers studies on environment and information studies, policy management, business and commerce, medicine, nursing and pharmaceutical sciences. The university provides elementary education through its schools, and university hospital. It operates through its campuses located in Mita, Hiyoshi, Yagami, Shinanomachi, Tonomachi, Tsuruoka, and others. Keio is headquartered in Tokyo, Japan.

Keio University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Keio University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Keio University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Keio University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Keio University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Keio University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Keio University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Eisai Enters into Agreement with Keio University 10
Takeda Enters into Research Agreement with Keio University School of Medicine and Niigata University 11
R-Tech Ueno Enters Into Co-Development Agreement With Keio University School Of Medicine 12
tella Enters into Research Agreement with Keio University School of Medicine 13
tella Enters into Research Agreement with Keio University School of Medicine for Esophageal Cancer 14
Licensing Agreements 15
Elixirgen Enters into License Agreement with Keio University 15
Keio University – Key Competitors 16
Keio University – Key Employees 17
Keio University – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Keio University, Pharmaceuticals & Healthcare, Key Facts 2
Keio University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Keio University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Keio University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Keio University, Deals By Therapy Area, 2011 to YTD 2017 8
Keio University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Eisai Enters into Agreement with Keio University 10
Takeda Enters into Research Agreement with Keio University School of Medicine and Niigata University 11
R-Tech Ueno Enters Into Co-Development Agreement With Keio University School Of Medicine 12
tella Enters into Research Agreement with Keio University School of Medicine 13
tella Enters into Research Agreement with Keio University School of Medicine for Esophageal Cancer 14
Elixirgen Enters into License Agreement with Keio University 15
Keio University, Key Competitors 16
Keio University, Key Employees 17
Keio University, Other Locations 18
Keio University, Subsidiaries 18

★海外企業調査レポート[Keio University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shelby Energy Cooperative, Inc.:企業の発電所・SWOT分析2018
    Shelby Energy Cooperative, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Premier Oil plc:企業の戦略・SWOT・財務分析
    Premier Oil plc - Strategy, SWOT and Corporate Finance Report Summary Premier Oil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Axcelis Technologies Inc (ACLS):企業の財務・戦略的SWOT分析
    Summary Axcelis Technologies Inc (Axcelis) operates as a technology company that provides industrial equipment and services for semiconductor industries. The company’s offers ion implantation product, which include high current implanters, purion H, optima HDx, high energy purion XE, optima XEx, par …
  • Beckman Coulter, Inc.:企業のM&A・事業提携・投資動向
    Beckman Coulter, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Beckman Coulter, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Northwest Territories Power Corp:企業の発電所・SWOT分析2018
    Northwest Territories Power Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Keio University-製薬・医療分野:企業M&A・提携分析
    Summary Keio University (Keio) is an educational institution that offers academic and research in various fields. The university provides primary and secondary education, graduate and undergraduate courses, and information technology courses. It offers academic courses in the field of economics, law …
  • Watt’s S.A.:企業の戦略・SWOT・財務情報
    Watt's S.A. - Strategy, SWOT and Corporate Finance Report Summary Watt's S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sharps Compliance Corp (SMED):企業の財務・戦略的SWOT分析
    Summary Sharps Compliance Corp (Sharps) is a healthcare waste solution company that offers regulatory compliant services. The company offers products such as sharps disposal systems, public sharps safety, takeaway medication recovery system, collection and disposal system, complete needle collection …
  • Neuravi Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Neuravi Ltd (Neuravi) is a medical device company that develops and commercializes endovascular devices and stroke treatment. The company provides embotrap revascularization device which is a thrombectomy system designed with clot-device mechanics to address challenging occlusions. Its embot …
  • AutoNation, Inc.:企業の戦略・SWOT・財務情報
    AutoNation, Inc. - Strategy, SWOT and Corporate Finance Report Summary AutoNation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The Toronto-Dominion Bank:企業の戦略・SWOT・財務情報
    The Toronto-Dominion Bank - Strategy, SWOT and Corporate Finance Report Summary The Toronto-Dominion Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Lassila & Tikanoja plc:企業のM&A・事業提携・投資動向
    Lassila & Tikanoja plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lassila & Tikanoja plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Acadia Pharmaceuticals Inc (ACAD):企業の財務・戦略的SWOT分析
    Acadia Pharmaceuticals Inc (ACAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Senju Pharmaceutical Co Ltd:企業の戦略的SWOT分析
    Senju Pharmaceutical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Bright Food (Group) Co Ltd:企業のM&A・事業提携・投資動向
    Bright Food (Group) Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bright Food (Group) Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Rich Pharmaceuticals Inc (RCHA):製薬・医療:M&Aディール及び事業提携情報
    Summary Rich Pharmaceuticals Inc (Rich Pharmaceuticals) is a biopharmaceutical company that offers discovery and development of therapies for the treatment of acute myelogenous leukemia (AML) in refractory patients. The company’s pipeline portfolio offers a lead drug candidate for the treatment of a …
  • Suntory Beverage & Food Limited:企業の戦略・SWOT・財務分析
    Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report Summary Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Tarsa Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tarsa Therapeutics Inc (Tarsa) is a developer of therapies for the treatment and prevention of osteoporosis and other bone related diseases. The company develops calcitonin tablet TBRIA, an oral formulation of calcitonin, a peptide hormone that inhibits bone resorption, which is used for the …
  • Alfresa Holdings Corp (2784):製薬・医療:M&Aディール及び事業提携情報
    Summary Alfresa Holdings Corp (Alfresa) is a manufacturer and marketer of pharmaceuticals, diagnostic reagent and medical devices. The company offers ethical pharmaceuticals wholesaling, self-medication products and manufacturing. It’s ethical pharmaceutical wholesaling business supplies diagnostic …
  • C.H. Bailey PLC:企業の戦略・SWOT・財務情報
    C.H. Bailey PLC - Strategy, SWOT and Corporate Finance Report Summary C.H. Bailey PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆